Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2026-01-13 @ 8:09 AM
Study NCT ID:
NCT01940900
Status:
TERMINATED
Last Update Posted:
2024-10-30
First Post:
2013-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy
Sponsor:
Ophthotech Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
None
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-09
First Submit QC Date:
None
Study First Post Date:
2013-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-11
Results First Submit QC Date:
None
Results First Post Date:
2018-08-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-19
Last Update Post Date:
2024-10-30
Last Update Post Date Type:
ACTUAL